Wegovy and Zepbound prices fall, but access to the obesity drugs still isn’t guaranteed
By TOM MURPHY, AP Health Writer Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The medications still amount to around $500 per month for those without insurance — out of reach for many patients. And even for people with insurance, coverage remains uneven. “The medications should […]
Ozempic-Like Drug Liraglutide Slashes Migraine Days In Half, Study Finds
A new pilot study suggests that liraglutide, a GLP-1RA prescribed for diabetes and weight management, could help reduce migraine frequency. MementoJpeg/Getty Images An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say liraglutide might help migraine frequency and severity by reducing intracranial pressure. While promising, it’s too […]
Wegovy and Zepbound prices are dropping, but steady access to the weight-loss drugs remains a challenge
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The medications still amount to around $500 per month for those without insurance—out of reach for many patients. And even for people with insurance, coverage remains uneven. “The medications should be available, the question is at […]
Optimal Data Sources for Studies of Incident Dementia
In JAMA Internal Medicine, Luchsinger et al describe the results of a prespecified secondary analysis of the GRADE clinical trial on cognitive performance. The GRADE trial randomized 3721 patients with type 2 diabetes using metformin at baseline to add either a long-acting insulin, a sulfonylurea, a glucagon-like peptide-1 (GLP-1) agonist, or a dipeptidyl peptidase-4 inhibitor. […]
H.C. Wainwright Reiterates a Buy Rating on Opko Health (OPK), Keeps the PT at $3
Opko Health Inc. (NASDAQ:OPK) is one of the 13 Stocks Under $5 With High Upside Potential. On May 1, analyst Yi Chen of H.C. Wainwright reiterated a Buy rating on Opko Health Inc. (NASDAQ:OPK), retaining the price target of $3.00. Despite mixed fiscal Q1 2025 results, the rating was supported by future prospects and strategic […]
🔥 Drink This Before Bed — It Forces Belly Fat to Burn Overnight | Dr. Mandell
If you’re struggling with stubborn belly fat, especially as you age, this simple nighttime drink may help reset your body’s fat-burning hormones while you sleep. It’s a natural, science-backed mix of Matcha, cinnamon, apple cider vinegar, and lemon is designed to work with your metabolism, not against it. Matcha stimulates thermogenesis and gently raises your […]
Exercise and a plant-based diet healthiest way to lose weight as compared to weight-loss drugs: Survey
NEW DELHI: As weight-loss drugs like semaglutide and tirzepatide dominate global headlines, a new nationwide survey shows that 87 per cent of Indian adults believe it is important to learn about non-drug-supported weight loss methods, following concerns over safety and long-term use. The study, which was conducted among 1,000 people residing in Delhi, Mumbai, Bangalore, and […]
‘King Kong’ of fat jabs ‘help you TONE up’ – as scientists discover surprising ‘fitness boost’
A NEW study challenges the idea that weight loss jabs decrease muscle mass, alongside fat. Scientists say one injection – known as the ‘King Kong’ of weight loss jabs – may swerve this side effect. GettyThe weight loss jab Mounjaro leads to no more muscle loss than you’d get from losing weight without the medication[/caption] […]
Caution is prescribed for American Academy of Paediatrics’ guidelines on weight loss medications for childhood obesity
Prescribing glucagon-like peptide 1 (GLP-1) receptor agonists such as semaglutide or tirzepatide for weight loss has created vigorous scientific debate. Four recent reviews in The BMJ conclude that GLP-1 agonists are highly effective for weight loss and may improve outcomes in people with conditions associated with obesity.1234 Yet concerns exist about their side effects,1234 safety […]
Obesity drug prices are dropping, but getting a steady supply remains a challenge – AP News
Obesity drug prices are dropping, but getting a steady supply remains a challenge AP News Contributor: Here’s how to get GLP-1 drugs covered by employer health insurance Los Angeles Times CVS dropped Zepbound in standard coverage. What that means for Zepbound users IndyStar Insurance cutbacks on costly GLP-1 coverage are good for small businesses The Boston Globe Major insurance […]